Wolfram syndrome 1b mutation suppresses Mauthner-cell axon regeneration via ER stress signal pathway
Acta Neuropathol Commun. 2022 Dec 17;10(1):184. doi: 10.1186/s40478-022-01484-8. ABSTRACT Wolfram Syndrome (WS) is a fatal human inherited disease with symptoms of diabetes, vision decreasing, and neurodegeneration caused by mutations in the endoplasmic reticulum (ER)-resident protein WFS1. WFS1 has been reported to play an important role in glucose metabolism. However, the role of WFS1 in axonal […]
Rejuvenation: Turning Back Time by Enhancing CISD2
Int J Mol Sci. 2022 Nov 13;23(22):14014. doi: 10.3390/ijms232214014. ABSTRACT The aging human population with age-associated diseases has become a problem worldwide. By 2050, the global population of those who are aged 65 years and older will have tripled. In this context, delaying age-associated diseases and increasing the healthy lifespan of the aged population has […]
Case report: De novo pathogenic variant in WFS1 causes Wolfram-like syndrome debuting with congenital bilateral deafness
Front Genet. 2022 Oct 18;13:998898. doi: 10.3389/fgene.2022.998898. eCollection 2022. ABSTRACT Background: Congenital deafness could be the first manifestation of a syndrome such as in Usher, Pendred, and Wolfram syndromes. Therefore, a genetic study is crucial in this deficiency to significantly improve its diagnostic efficiency, to predict the prognosis, to select the most adequate treatment required, […]
Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum
Surv Ophthalmol. 2023 Feb 8:S0039-6257(23)00035-8. doi: 10.1016/j.survophthal.2023.01.012. Online ahead of print. ABSTRACT Wolfram-like syndrome (WFLS) is a recently described autosomal dominant disorder with phenotypic similarities to autosomal recessive Wolfram syndrome (WS), including optic atrophy, hearing impairment, and diabetes mellitus. We summarize current literature, define the clinical characteristics, and investigate potential genotype phenotype correlations. A systematic […]
Modeling disrupted synapse formation in wolfram syndrome using hESCs-derived neural cells and cerebral organoids identifies Riluzole as a therapeutic molecule
Mol Psychiatry. 2023 Feb 7. doi: 10.1038/s41380-023-01987-3. Online ahead of print. ABSTRACT Dysregulated neurite outgrowth and synapse formation underlie many psychiatric disorders, which are also manifested by wolfram syndrome (WS). Whether and how the causative gene WFS1 deficiency affects synapse formation remain elusive. By mirroring human brain development with cerebral organoids, WFS1-deficient cerebral organoids not […]
β-cyclodextrin based nano gene delivery using pharmaceutical applications to treat Wolfram syndrome
Ther Deliv. 2022 Sep;13(9):449-462. doi: 10.4155/tde-2022-0036. Epub 2023 Feb 7. ABSTRACT Wolfram syndrome is a rare multisystem autosomal recessive neurodegenerative disorder that affects the brain and central nervous system. Currently, there is no cure or treatment for Wolfram syndrome. Therefore, new techniques are needed to target the loss of the WFS1 gene. Gene therapy approach […]
Endoplasmic reticulum stress inhibition ameliorated WFS1 expression alterations and reduced pancreatic islets’ insulin secretion induced by high-fat diet in rats
Sci Rep. 2023 Feb 1;13(1):1860. doi: 10.1038/s41598-023-28329-1. ABSTRACT Endoplasmic reticulum (ER) stress is involved in the development of glucose homeostasis impairment. When ER stress occurs, the unfolded protein response (UPR) is activated to cope with it. One of the UPR components is WFS1 (Wolfram syndrome 1), which plays important roles in ER homeostasis and pancreatic […]
Psychiatric Diagnoses and Medications in Wolfram Syndrome
Scand J Child Adolesc Psychiatr Psychol. 2022 Dec 31;10(1):163-174. doi: 10.2478/sjcapp-2022-0017. eCollection 2022 Jan. ABSTRACT BACKGROUND: Wolfram Syndrome is a rare genetic disorder usually resulting from pathogenic variation in the WFS1 gene, which leads to an exaggerated endoplasmic reticulum (ER) stress response. The disorder is typically characterized by diabetes insipidus, diabetes mellitus, optic nerve atrophy, […]
MCT1-dependent energetic failure and neuroinflammation underlie optic nerve degeneration in Wolfram syndrome mice
Elife. 2023 Jan 16;12:e81779. doi: 10.7554/eLife.81779. ABSTRACT Wolfram syndrome 1 (WS1) is a rare genetic disorder caused by mutations in the WFS1 gene leading to a wide spectrum of clinical dysfunctions, among which blindness, diabetes, and neurological deficits are the most prominent. WFS1 encodes for the endoplasmic reticulum (ER) resident transmembrane protein wolframin with multiple […]
A Pair of Siblings With Wolfram Syndrome: A Review of the Literature and Treatment Options
J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096221150631. doi: 10.1177/23247096221150631. ABSTRACT Wolfram syndrome (WS) is a rare genetic disorder typically characterized by juvenile onset diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, and neurodegeneration. There would be a high index of clinical suspicion for WS when clinical manifestations of type 1 diabetes and optic […]